Literature DB >> 11682619

cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.

C Bousquet1, V Chesnokova, A Kariagina, A Ferrand, S Melmed.   

Abstract

The hypothalamo-pituitary-adrenal (HPA) axis maintains a homeostatic response to stress, infection, or neoplasia. Inflammatory cytokines, including leukemia inhibitory factor (LIF), stimulate the HPA axis either directly at the pituitary corticotroph, or indirectly through induction of CRH or sympathetic noradrenergic neurons, and mediate the immuno-neuroendocrine interface. Unrestrained HPA axis activation leads, however, to immunosuppression. Because suppressor of cytokine signaling-3 (SOCS-3) is a potent inhibitor of LIF-activated HPA axis, and dynamic interactions between hypothalamus-derived cAMP-inducing neuropeptides and proinflammatory cytokines occur at the corticotroph level, we investigated SOCS-3 expression in response to peptides that stimulate cAMP including CRH, pituitary adenylate cyclase-activating polypeptide, and epinephrine. (Bu)2cAMP mediates induction of SOCS-3 promoter activity (6.7-fold +/- 0.5, P < 0.001) and SOCS-3 gene expression (4-fold +/- 0.8, P < 0.005) in a PKA-dependent manner. LIF and cAMP-inducing agents are additive on SOCS-3 promoter activity (22-fold +/- 2.6, LIF + (Bu)2cAMP vs. 7.3-fold +/- 0.6, LIF alone, P < 0.05) and on SOCS-3 transcription (11.3-fold +/- 2.1, LIF + (Bu)2cAMP vs. 9.3-fold +/- 1, LIF alone, P < 0.05), suggesting alternate pathways for LIF and cAMP-mediated corticotroph signaling. Similarly, LIF and CRH or pituitary adenylate cyclase-activating polypeptide are additive for SOCS-3 promoter activity and transcription (P < 0.05). Whereas signal transducer and activator of transcription 3 binding to the SOCS-3 promoter mediates LIF action, several SOCS-3 promoter regions containing cAMP-responsive elements are required for cAMP-PKA effect. Thus, both classes of POMC-inducing agents, cytokines as well as cAMP-inducing central peptides, regulate SOCS-3, providing a further level of negative HPA axis control during inflammation. These results indicate a sensitive intracellular autoregulation of corticotroph function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682619     DOI: 10.1210/mend.15.11.0733

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

Review 1.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

Authors:  C J Auernhammer; S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways.

Authors:  E Arzt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 3.  Series introduction. The immuno-neuroendocrine interface.

Authors:  S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 4.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

5.  Induction of leptin resistance by activation of cAMP-Epac signaling.

Authors:  Makoto Fukuda; Kevin W Williams; Laurent Gautron; Joel K Elmquist
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

6.  STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Authors:  Yi Li; Jasper Deuring; Maikel P Peppelenbosch; Ernst J Kuipers; Colin de Haar; C Janneke van der Woude
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

7.  Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.

Authors:  Juliana Xu; Renia Sylvester; Ann P Tighe; Siming Chen; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

8.  Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer.

Authors:  Ilaria Bellezza; Hannes Neuwirt; Constanze Nemes; Ilaria T Cavarretta; Martin Puhr; Hannes Steiner; Alba Minelli; Georg Bartsch; Felix Offner; Alfred Hobisch; Wolfgang Doppler; Zoran Culig
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

9.  Hypothalamic PKA regulates leptin sensitivity and adiposity.

Authors:  Linghai Yang; G Stanley McKnight
Journal:  Nat Commun       Date:  2015-09-18       Impact factor: 14.919

Review 10.  Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review.

Authors:  Margaret F Keil; George Briassoulis; Constantine A Stratakis; T John Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-29       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.